Next Article in Journal
Understanding the Role of Negative Emotions in Adult Learning and Achievement: A Social Functional Perspective
Next Article in Special Issue
Age-Related Changes in the Behavior of Apolipoprotein E Knockout Mice
Previous Article in Journal
The Effect of Active Creation on Psychological Health: A Feasibility Study on (Therapeutic) Mechanisms
Previous Article in Special Issue
Tyrosine Hydroxylase, Vesicular Monoamine Transporter and Dopamine Transporter mRNA Expression in Nigrostriatal Tissue of Rats with Pedunculopontine Neurotoxic Lesion
Open AccessFeature PaperArticle

Neuroprotective Effects of neuroEPO Using an In Vitro Model of Stroke

Department of Animal Health, University of Nariño, Pasto 52001, Nariño, Colombia
Institute of Basic and Preclinical Sciences “Victoria de Girón”, Havana 10400, Cuba
CETEX, CENPALAB, Havana 10800, Cuba
Department Cellular Biology, Physiology and Immunology, University of Barcelona, 08007 Barcelona, Spain
Author to whom correspondence should be addressed.
Behav. Sci. 2018, 8(2), 26;
Received: 24 November 2017 / Revised: 9 February 2018 / Accepted: 10 February 2018 / Published: 13 February 2018
(This article belongs to the Special Issue State of Art in Non-Clinical Models for Neurodegenerative Diseases)
PDF [2272 KB, uploaded 13 February 2018]
  |     |  


Erythropoietin (EPO) is a glycoprotein initially identified as a hormone synthesized and secreted by the kidney that regulates erythropoiesis. EPO, and a group of its derivatives, are being evaluated as possible neuroprotective agents in cerebral ischemia. The objective of this study, using an in vitro model, was to determine how neuroEPO—which is a variant of EPO with a low sialic acid content—protects neurons from the toxic action of glutamate. Primary neuronal cultures were obtained from the forebrains of Wistar rat embryos after 17 days of gestation. Excitotoxicity was induced after nine days of in vitro culture by treatment with a medium containing 100 µM glutamate for 15 min. After this time, a new medium containing 100 ng of neuroEPO/mL was added. Morphological cell change was assessed by phase-contrast microscopy. Oxidative stress was analysed by measuring antioxidant and oxidant activity. After 24 h, the treatment with 100 ng of neuroEPO/mL showed a significant (p < 0.01) decrease in mortality, compared to cells treated with glutamate alone. neuroEPO treatment decreased mortality and tended to reproduce the morphological characteristics of the control. The oxidative stress induced by glutamate is reduced after neuroEPO treatment. These results confirm that neuroEPO has a protective effect against neuronal damage induced by excitotoxicity, improving antioxidant activity in the neuron, and protecting it from oxidative stress. View Full-Text
Keywords: stroke; primary cortical neuron culture; excitotoxicity; oxidative stress; neuroEPO; neuroprotection stroke; primary cortical neuron culture; excitotoxicity; oxidative stress; neuroEPO; neuroprotection

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Fernando, G.; Yamila, R.; Cesar, G.J.; Ramón, R. Neuroprotective Effects of neuroEPO Using an In Vitro Model of Stroke. Behav. Sci. 2018, 8, 26.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Behav. Sci. EISSN 2076-328X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top